Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?

Management of metastatic radioiodine refractory differentiated thyroid cancer (DTC) can be a therapeutic challenge. Generally, little is known about the paired molecular profile of the primary tumor and the metastases and whether they harbor the same genetic abnormalities. The present study compared...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Endocrinol (Lausanne)
Main Authors: Gomes-Lima, Cristiane J., Shobab, Leila, Wu, Di, Ylli, Dorina, Bikas, Athanasios, McCoy, Matthew, Feldman, Rebecca, Lee, Wen, Rao, Sarika N., Jensen, Kirk, Vasko, Vasily, Castro, Luiz Claudio, Jonklaas, Jacqueline, Wartofsky, Leonard, Burman, Kenneth D.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Endocrinology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7949910/
https://ncbi.nlm.nih.gov/pubmed/33716974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.623182
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados